PERJETA-HERCEPTIN

Google image searchProduct monograph

Active ingredients

pertuzumab, 420 MG/14 ML

trastuzumab, 440 MG/VIAL

DIN: 02405024

Dosage form(s): SOLUTION, KIT, POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: COMBO PACK

Schedule: Prescription / Schedule D

Company: HOFFMANN-LA ROCHE LIMITED

Date: 09-MAY-2013

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FY — Combinations of monoclonal antibodies and antibody drug conjugates (ATC, ATC/DDD)
• L01FY01 — PERTUZUMAB AND TRASTUZUMAB (ATC/DDD)

External Links for Perjeta-Herceptin

Search on Google

• Perjeta-Herceptin side effects
• Perjeta-Herceptin dosage
• pertuzumab side effects
• pertuzumab dosage
• trastuzumab side effects
• trastuzumab dosage

Hoffmann-La Roche Limited

Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find perjeta-herceptin photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.